Search

Electric vehicle (EV) batteries are often underutilized. Vehicle-to-grid (V2G) services can tap into this unused potential, but increased battery usage may lead to more degradation and shorter battery life. This paper substantiates the advantages of providing load-shifting V2G services when the battery is aging, primarily due to calendar aging mechanisms (active degradation mechanisms while the battery is not used). After parameterizing a physics-based digital-twin for three different dominant degradation patterns within the same chemistry (NMC), we introduce a novel metric for evaluating the benefit and associated harm of V2G services: \textit{throughput gained versus days lost (TvD)} and show its strong relationship to the ratio of loss of lithium inventory (LLI) due to calendar aging to the total LLI ($\text{LLI}_\text{Cal}/\text{LLI}$). Our results that focus systematically on degradation mechanisms via lifetime simulation of digital-twins significantly expand prior work that was primarily concentrating on quantifying and reducing the degradation of specific cells by probing their usage and charging patterns. Examining various cell chemistries and conditions enables us to take a broader view and determine whether a particular battery pack is appropriate for load-shifting (V2G) services. Our research demonstrates that the decision "to V2G or not to V2G" can be made by merely estimating the portion of capacity deterioration caused by calendar aging. Specifically, TvD is primarily influenced by the chemistry of cells and the environmental temperature where the car is parked, while the usage intensity and charging patterns of EVs play a lesser role.

Nasogastric tubes (NGTs) are feeding tubes that are inserted through the nose into the stomach to deliver nutrition or medication. If not placed correctly, they can cause serious harm, even death to patients. Recent AI developments demonstrate the feasibility of robustly detecting NGT placement from Chest X-ray images to reduce risks of sub-optimally or critically placed NGTs being missed or delayed in their detection, but gaps remain in clinical practice integration. In this study, we present a human-centered approach to the problem and describe insights derived following contextual inquiry and in-depth interviews with 15 clinical stakeholders. The interviews helped understand challenges in existing workflows, and how best to align technical capabilities with user needs and expectations. We discovered the trade-offs and complexities that need consideration when choosing suitable workflow stages, target users, and design configurations for different AI proposals. We explored how to balance AI benefits and risks for healthcare staff and patients within broader organizational and medical-legal constraints. We also identified data issues related to edge cases and data biases that affect model training and evaluation; how data documentation practices influence data preparation and labelling; and how to measure relevant AI outcomes reliably in future evaluations. We discuss how our work informs design and development of AI applications that are clinically useful, ethical, and acceptable in real-world healthcare services.